PLoS ONEGenetic & Genomic MedicinePeer-reviewed journal article
Prevalence and spectrum of germline BRCA1 and BRCA2 mutations in multiethnic cohort of breast cancer patients in Brunei Darussalam
Siti Nur Idayu MatusiniD, Nuramalina H MuminiD, Hazirah Zainal Abidin, Fatin Nurizzati Mohd JayaiD, Zen Huat LuiD, Mas Rina Wati Haji Abdul HamidiD
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 13th percentile
Abstract
This is the first genetic study of its kind in Brunei Darussalam. BRCA1 and BRCA2 genes are the most well-known and well described predictors of hereditary breast cancer due to their clinical importance. This study aimed to identify the prevalence and mutation spectrum of the BRCA1 and BRCA2 germline mutations among 120 unselected series of Brunei breast cancer patients. We screened the entire coding region of BRCA1 and BRCA2 gene using Sanger sequencing and next-generation sequencing methods, and identified three pathogenic and one likely pathogenic mutations in the BRCA2 gene. Of the 120 patients, 6 (5%) were BRCA2 carriers which confirm that BRCA2 carriers are more common in the Asian population compared to the Caucasian population. One BRCA2 mutation observed only in the Chinese ethnicity of the Brunei breast cancer population contributes to the probability of the mutation being a founder effect in the Southern Chinese population. Brunei BRCA2 carriers were more likely to have a positive family history of breast and/or ovarian cancers and have more than one family members in the first-degree relatives diagnosed with breast cancer.
- organism: human
- assay: whole-exome sequencing
- research focus: variant calling
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Assessing the variations in breast/ovarian cancer risk for Chinese BRCA1/2 carriers
Ang Li, Yi Zi, … Yujian Shi·Journal of OncologyPeer-reviewed·Mar 26, 2022
- Germline Mutation Analysis in Sporadic Breast Cancer Cases with Clinical Correlations
Sadia Ajaz, Sani-e-Zehra Zaidi, … Muhammad Ali Memon·Frontiers in GeneticsPeer-reviewed·Mar 9, 2022
- Very high frequencies of Familial Breast Cancer, low BRCA1/2 mutations and high Luminal molecular subtypes in Eastern Saudi Arabia necessitate the hunt for novel breast cancer hub genes
T. Al-Qurashi, S. Balghonaim, … Z. Iqbal·medRxiv·Oct 3, 2023
- Assessing germline mutational profile and its clinicopathological associations in Triple Negative Breast Cancer
Jisha John, Ashwini C. Bapat, … Chaitanyanand B. Koppiker·Cancer GeneticsPeer-reviewed·Jun 18, 2025
- The genetics of hereditary cancer risk syndromes in Brazil: a comprehensive analysis of 1682 patients
Jarbas Maciel de Oliveira, Nuria Bengala Zurro, … João Bosco Oliveira·European Journal of Human GeneticsPeer-reviewed·May 9, 2022
- Hereditary breast cancer next-generation sequencing (NGS) panel evaluation in the south region of Brazil: a novel BRCA2 candidate pathogenic variant is reported.
César Augusto Barros Duarte, C. A. M. dos Santos, … Sueli Massumi Nakatani·medRxiv·Feb 8, 2024